Nektar Therapeutics to Participate in the Jefferies Global Healthcare Conference in London
SAN FRANCISCO, Oct. 30, 2025 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR) today announced that company management will be webcasting its…
FDA Issues Formal Guideline Waiving Clinical Efficacy Studies for Biosimilars, Confirming Professor Niazi’s 15-Year Campaign to Cut Biologic Drug Costs
A Landmark Regulatory Shift Validates Professor Sarfaraz K. Niazi’s Vision to Make Biologics as Affordable as Generics CHICAGO,…
1 Ranked Institute, IIT Madras & Danish University Study reveals Genetic ‘Switches’ that can transform Disease Research
CHENNAI, India, Oct. 8, 2025 /CNW/ — India’s No:1 Ranked Institute, the Indian Institute of Technology Madras, and…
3D Cell Culture Market worth US$2.26 billion by 2030 with 11.7% CAGR
DELRAY BEACH, Fla., Oct. 6, 2025 /PRNewswire/ — The global 3D Cell Culture Market, valued at US$1.18 billion in…
Lilly’s Kisunla (donanemab) receives marketing authorization by European Commission for the treatment of early symptomatic Alzheimer’s disease
Approved for earliest symptomatic stages of disease, demonstrating significant slowing of cognitive and functional decline Only therapy with…
Quest Diagnostics to Improve Laboratory Testing Experience with Industry-First Epic Collaboration
With the most comprehensive Epic integration by a laboratory provider, collaboration will streamline and strengthen the customer experience…
Stealth BioTherapeutics Announces FDA Accelerated Approval of FORZINITY™ (elamipretide HCl), the First Therapy for Progressive and Life-limiting Ultra-rare Genetic Disease Barth Syndrome
NEEDHAM, Mass., Sept. 19, 2025 /PRNewswire/ — Stealth BioTherapeutics Inc. (the “Company” or “Stealth”), a commercial-stage biotechnology company focused…
Sleep Aids Market to Hit US$ 118.97 Billion by 2033, Growing at 7.8% CAGR
AUSTIN, Texas and TOKYO, Sept. 19, 2025 /PRNewswire/ — According to DataM Intelligence, the global sleep aids market…